Galluppi Stefan
- SEC CIK
- 0001722649
No open-market purchases or sales filed in the past year.
Current role at each company
- LFMD LifeMD, Inc.Chief Innovation Officeras of Aug 26, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Galluppi Stefan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2021 (view filing) | Nov 15 | 1 day | Galluppi StefanChief Technology Officer | PPurchaseCommon Stock, par value $0.01 | +2.20K | $4.55 | +$10.0K | +57.9%5.99K after | 2 lots |
| Nov 18, 2021 (view filing) | Nov 17 | 1 day | Galluppi StefanChief Technology Officer | PPurchaseCommon Stock, par value $0.01 | +1.85K | $4.80 | +$8.87K | +30.8%7.84K after | 3 lots |
| May 31, 2023 (view filing) | May 23 | 8 days | Galluppi StefanChief Innovation Officer | PPurchaseCommon Stock, par value $0.01 | +4.61K | $2.17 | +$10.0K | +58.8%12.4K after | Amended |
| Sep 12, 2024 (view filing) | Sep 11 | 1 day | Galluppi StefanChief Innovation Officer | PPurchase | +3.00K | $4.93 | +$14.8K | +7.1%45.4K after | |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Galluppi StefanChief Innovation Officer | SSale | −85.0K | $12.38 | −$1.05M | −51.4%80.4K after | 10b5-1 |